Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Transplantation Proceedings|May 20, 1999
Generic immunosuppressant use in solid organ transplantationR R AllowayBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Pancreas transplantation for diabetes mellitus: a guide to recipient selection and optimum immunosuppressionR J Stratta, R R AllowayTransplantation Proceedings|November 22, 2005
Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantationJ Rogers, R J Stratta, A Lo, et al.Transplantation Proceedings|November 22, 2005
Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipientsJ Rogers, R J Stratta, A Lo, et al.Transplantation Proceedings|November 22, 2005
Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipientsR J Stratta, R R Alloway, A Lo, et al.Transplantation Proceedings|June 15, 2004
One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumabR J Stratta, R R Alloway, A Lo, et al.Transplantation Proceedings|June 15, 2004
Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipientsR J Stratta, R R Alloway, A Lo, et al.Transplantation Proceedings|April 26, 2005
A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantationA Lo, R J Stratta, R R Alloway, et al.Transplantation|June 9, 2001
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipientsS Tuteja, R R Alloway, J A Johnson, et al.Transplantation Proceedings|November 22, 2005
A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 yearsR J Stratta, R R Alloway, A Lo, et al.Pageof 7